[Intracerebroventricular administration of adenosine A1 receptor antisense oligodeoxynucleotide inhibites the neuroprotective effect of the cerebral ischemic preconditioning in rats]. 2008

Xiao-jing Yun, and Yu-yan Hu, and Xiao-hui Xian, and Shu-qin Li, and Xiao-cai Sun, and Min Zhang, and Qing-jun Li, and Wen-bin Li
Department of Pathophysiology, Institute of Basic Medicine, Hebei Medical University, Shijiazhuang 050017, China.

OBJECTIVE To further explore the role of adenosine A1 receptor in the neuroprotective effect of cerebral ischemic preconditioning, the present study was undertaken to observe the effect of inhibiting expression of adenosine Al receptor with adenosine A1 receptor antisense oligodeoxynucleotide (ARA1 As-ODN) on the neuroprotective effect of cerebral ischemic preconditioning against delayed neuronal death (DND) normally induced by lethal brain ischemia. METHODS The rat 4-vessel occlusion global cerebral ischemic model was used. Forty-eight male Wistar rats with permanent occlusion of the bilateral vertebral arteries were divided into 8 groups: Sham, CIP, brain ischemic insult, CIP + brain ischemic insult, Distilled water + CIP + brain ischemic insult, ARA1 As-ODN, ARA1 As-ODN +CIP, ARA1 As-ODN+ CIP + brain ischemic insult(two doses of 10 nmol/5 microl and 20 nmol/5 microl were used) groups. ARA1 As-ODN was dissolved in distilled water and injected into the right lateral cerebral ventricle. To illustrate the profile of DND, histological grade (HG) and neuronal density (ND) in the CA1 region of the hippocampus were examined 7 d after the sham operation or the last time of ischemia under thionin staining. RESULTS The HG and ND in CIP group were similar to those in sham group. Brain ischemic insult induced obvious DND as represented with the increase in HG and decrease in ND significantly (P < 0.05 vs. sham and CIP groups). In CIP + ischemic insult group,no obvious DND was observed,which indicated that CIP protected pyramidal neurons against the ischemic insult.While the administration of ARA1 As-ODN in ARA1 As-ODN + CIP + brain ischemic insult group caused obvious increase in HG and decrease in ND compared with CIP + brain ischemic insult group (P < 0.05) in a dose dependent manner,which indicated that the neuroprotective effect of CIP against DND of hippocampal pyramidal neurons normally induced by ischemic insult was inhibited by the administration of ARA1 As-ODN. CONCLUSIONS The results further demonstrate the association of up-regulation of adenosine A1 receptors with the induction of CIP-mediated BIT.

UI MeSH Term Description Entries
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D043682 Receptor, Adenosine A1 A subtype of ADENOSINE RECEPTOR that is found expressed in a variety of tissues including the BRAIN and DORSAL HORN NEURONS. The receptor is generally considered to be coupled to the GI, INHIBITORY G-PROTEIN which causes down regulation of CYCLIC AMP. Adenosine A1 Receptors,Adenosine A1 Receptor,Receptors, Adenosine A1
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D057967 Infusions, Intraventricular The delivery of a drug into a fluid-filled cavity of the brain. Infusions, Intracerebroventricular,Infusion, Intracerebroventricular,Infusion, Intraventricular,Intracerebroventricular Infusion,Intracerebroventricular Infusions,Intraventricular Infusion,Intraventricular Infusions

Related Publications

Xiao-jing Yun, and Yu-yan Hu, and Xiao-hui Xian, and Shu-qin Li, and Xiao-cai Sun, and Min Zhang, and Qing-jun Li, and Wen-bin Li
April 1997, European journal of pharmacology,
Xiao-jing Yun, and Yu-yan Hu, and Xiao-hui Xian, and Shu-qin Li, and Xiao-cai Sun, and Min Zhang, and Qing-jun Li, and Wen-bin Li
June 2012, Brain research,
Xiao-jing Yun, and Yu-yan Hu, and Xiao-hui Xian, and Shu-qin Li, and Xiao-cai Sun, and Min Zhang, and Qing-jun Li, and Wen-bin Li
April 2006, American journal of physiology. Heart and circulatory physiology,
Xiao-jing Yun, and Yu-yan Hu, and Xiao-hui Xian, and Shu-qin Li, and Xiao-cai Sun, and Min Zhang, and Qing-jun Li, and Wen-bin Li
May 1995, European journal of pharmacology,
Xiao-jing Yun, and Yu-yan Hu, and Xiao-hui Xian, and Shu-qin Li, and Xiao-cai Sun, and Min Zhang, and Qing-jun Li, and Wen-bin Li
May 1995, Proceedings of the National Academy of Sciences of the United States of America,
Xiao-jing Yun, and Yu-yan Hu, and Xiao-hui Xian, and Shu-qin Li, and Xiao-cai Sun, and Min Zhang, and Qing-jun Li, and Wen-bin Li
May 2010, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Xiao-jing Yun, and Yu-yan Hu, and Xiao-hui Xian, and Shu-qin Li, and Xiao-cai Sun, and Min Zhang, and Qing-jun Li, and Wen-bin Li
October 2005, British journal of pharmacology,
Xiao-jing Yun, and Yu-yan Hu, and Xiao-hui Xian, and Shu-qin Li, and Xiao-cai Sun, and Min Zhang, and Qing-jun Li, and Wen-bin Li
November 2016, Neurological research,
Xiao-jing Yun, and Yu-yan Hu, and Xiao-hui Xian, and Shu-qin Li, and Xiao-cai Sun, and Min Zhang, and Qing-jun Li, and Wen-bin Li
May 1993, The American journal of physiology,
Xiao-jing Yun, and Yu-yan Hu, and Xiao-hui Xian, and Shu-qin Li, and Xiao-cai Sun, and Min Zhang, and Qing-jun Li, and Wen-bin Li
September 1999, Cardiovascular research,
Copied contents to your clipboard!